These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37907467)

  • 1. Childbirth-related posttraumatic stress symptoms - examining associations with hair endocannabinoid concentrations during pregnancy and lifetime trauma.
    Bergunde L; Karl M; Schälicke S; Weise V; Mack JT; von Soest T; Gao W; Weidner K; Garthus-Niegel S; Steudte-Schmiedgen S
    Transl Psychiatry; 2023 Oct; 13(1):335. PubMed ID: 37907467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hair glucocorticoids during pregnancy in the context of trauma exposure and their predictive value for the development of childbirth-related posttraumatic stress disorder symptoms.
    Steudte-Schmiedgen S; Schälicke S; Bergunde L; Karl M; Weise V; Junge-Hoffmeister J; Schumacher S; von Soest T; Weidner K; Kirschbaum C; Garthus-Niegel S
    Psychoneuroendocrinology; 2023 Feb; 148():105973. PubMed ID: 36481577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swiss cohort on Traumatic Childbirth and Health (SwiTCH): protocol for a prospective, population-based cohort study on parents' mental health from pregnancy to one year postpartum.
    Chanvrier H; Rattaz V; Offredi V; Dupuis M; Horsch A
    BMJ Open; 2024 Jan; 14(1):e080557. PubMed ID: 38296274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model of risk for perinatal posttraumatic stress symptoms.
    Grekin R; O'Hara MW; Brock RL
    Arch Womens Ment Health; 2021 Apr; 24(2):259-270. PubMed ID: 32995950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal course of endocannabinoids and
    Hitzler M; Matits L; Gumpp AM; Bach AM; Ziegenhain U; Gao W; Kolassa IT; Behnke A
    Psychol Med; 2023 Nov; 53(15):7446-7457. PubMed ID: 37198936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birth expectations, birth experiences and childbirth-related post-traumatic stress symptoms in mothers and birth companions: Dyadic investigation using response surface analysis.
    Buyukcan-Tetik A; Seefeld L; Bergunde L; Ergun TD; Dikmen-Yildiz P; Horsch A; Garthus-Niegel S; Oosterman M; Lalor J; Weigl T; Bogaerts A; Van Haeken S; Downe S; Ayers S
    Br J Health Psychol; 2024 Nov; 29(4):925-942. PubMed ID: 38926081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid concentrations in hair are associated with PTSD symptom severity.
    Wilker S; Pfeiffer A; Elbert T; Ovuga E; Karabatsiakis A; Krumbholz A; Thieme D; Schelling G; Kolassa IT
    Psychoneuroendocrinology; 2016 May; 67():198-206. PubMed ID: 26923850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
    Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R
    Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder - a pilot study.
    Wingenfeld K; Dettenborn L; Kirschbaum C; Gao W; Otte C; Roepke S
    Stress; 2018 Jul; 21(4):366-369. PubMed ID: 29546791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endocannabinoids and psychological outcomes in women with PTSD.
    Botsford C; Brellenthin AG; Cisler JM; Hillard CJ; Koltyn KF; Crombie KM
    J Anxiety Disord; 2023 Jan; 93():102656. PubMed ID: 36469982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD.
    Leen NA; de Weijer AD; van Rooij SJH; Kennis M; Baas JMP; Geuze E
    Chronic Stress (Thousand Oaks); 2022; 6():24705470221107290. PubMed ID: 35707677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personality factors and vulnerability to post-traumatic stress responses after childbirth.
    Price L; Centifanti L; Slade P
    Br J Clin Psychol; 2020 Nov; 59(4):480-502. PubMed ID: 32808684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive symptoms are negatively associated with hair N-arachidonoylethanolamine (anandamide) levels: A cross-lagged panel analysis of four annual assessment waves examining hair endocannabinoids and cortisol.
    Walther A; Kirschbaum C; Wehrli S; Rothe N; Penz M; Wekenborg M; Gao W
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110658. PubMed ID: 36252885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of hair cortisol concentrations in the prediction of PTSD symptoms following traumatic physical injury.
    Pacella ML; Hruska B; Steudte-Schmiedgen S; George RL; Delahanty DL
    Soc Sci Med; 2017 Feb; 175():228-234. PubMed ID: 28109728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-item screening of maternal or infant perceived life threat during childbirth prospectively associated with childbirth-related posttraumatic stress symptoms up to six months postpartum: two observational longitudinal studies.
    Gilbert L; Sandoz V; Deforges C; Horsch A
    Front Psychiatry; 2024; 15():1360189. PubMed ID: 38654730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort.
    deRoon-Cassini TA; Bergner CL; Chesney SA; Schumann NR; Lee TS; Brasel KJ; Hillard CJ
    Transl Psychiatry; 2022 Feb; 12(1):48. PubMed ID: 35105857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal childbirth-related posttraumatic stress symptoms, bonding, and infant development: a prospective study.
    Devita S; Deforges C; Bickle-Graz M; Tolsa JF; Sandoz V; Horsch A
    J Reprod Infant Psychol; 2023 Sep; ():1-15. PubMed ID: 37740725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with post-traumatic stress symptoms (PTSS) 4-6 weeks and 6 months after birth: A longitudinal population-based study.
    Dikmen-Yildiz P; Ayers S; Phillips L
    J Affect Disord; 2017 Oct; 221():238-245. PubMed ID: 28654849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of concentration profiles of glucocorticosteroids and endocannabinoids in hair.
    Krumbholz A; Anielski P; Reisch N; Schelling G; Thieme D
    Ther Drug Monit; 2013 Oct; 35(5):600-7. PubMed ID: 23942543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postpartum post-traumatic stress symptoms during the COVID-19 period: exposure and fear as mediating factors.
    Shiffman N; Gluska H; Margalit S; Mayer Y; Daher R; Elyasyan L; Elia N; Sharon Weiner M; Miremberg H; Kovo M; Biron-Shental T; Gabbay-Benziv R; Helpman L
    Eur J Psychotraumatol; 2023; 14(2):2228151. PubMed ID: 37534932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.